Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Elan Corporation, plc (ELN) -- Ignore unavailable to you. Want to Upgrade?

To: William Partmann who wrote (1311)	11/7/2001 10:23:59 AM
From: tom pope	Read Replies (1) \| Respond to of 10345

Greenberg is right as often as not, and his questions about ELN's accounting should not be dismissed. Before being attacked as a lurking short, I own 1k shares of ELN, with a stop.

To: William Partmann who wrote (1311)	11/10/2001 10:28:39 AM
From: twentyfirstcenturyfox	Read Replies (1) \| Respond to of 10345

Does anyone on this thread do TA on this stock. Just curious to read what the charts say. TIA. Fox.

To: William Partmann who wrote (1311)	11/10/2001 10:55:16 AM
From: twentyfirstcenturyfox	Read Replies (1) \| Respond to of 10345

Bill any chance you could post the article here? I tried TSC, as a non-subscriber and all I could find was the Elan article by Greenberg dated 12/8/98. TIA. Fox.

To: William Partmann who wrote (1311)	11/11/2001 1:36:31 PM
From: arnie h	Respond to of 10345

Bill et al: Since, I'm a long term investor, my main concern with biotech companies is their technology. Through personal inspection and discussions, I satisfied myself that ELN scientists know what they're doing. They've got 1st rate science along with a strong pipeline of promising projects. With regard to 'weak' revenues; the same can no doubt be said for just about every company in the universe. It is one of the characteristics of the current stock market - mutual fund/analyst dominated climate. Today's analysts and many mutual fund managers have little patience and great difficulty in looking beyond the next Q, especially when it comes to high tech of any sort. Then they all pile on quickly if a company comes through with a winner. I'm delighted with Friday's approval as ELN continues to show they can develop their science and collaborations into commercial products. Good luck and thanks for keeping this board going. Arnie